Embold Therapeutics discovers and develops biologics for treatment of health conditions that occur later in life. Its focus is on neurodegenerative diseases such as Parkinson’s and Alzheimer’s Disease. The company is built on its extensive experience in engineering therapeutic enzymes for a range of metabolic rare diseases.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Redwood City, Ca 94062, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.emboldtx.com
- Keywords
- Parkinson's, Alzheimer's, Neurodegeneration, Enzyme, Enzyme Therapeutics, Enzyme Engineering, Directed Evolution, Protein Design, Protein AI, Replacement Therapy, Precision Medicine, Metabolism, Health span, Aging, Longevity.
- HQ
- Redwood City, CA
Embold Therapeutics Questions
Embold Therapeutics's website is http://www.emboldtx.com
Embold Therapeutics's LinkedIn profile is https://www.linkedin.com/company/embold-therapeutics
Embold Therapeutics has
3 employees.
View email and phone details for 3
employees at Embold Therapeutics.
Embold Therapeutics's industry is
Biotechnology Research
Embold Therapeutics's top competitors are
Enzyme Tech Consulting,
Codexis, Inc.,
Sciart Initiative,
Q-Acs,
Gfree Bio,
Crosswalk Therapeutics,
Biop2p Network,
Gate Scientific,
Soft Power,
Ichrom Solutions.
Embold Therapeutics's categories are Biotechnology Research
Embold Therapeutics's founding year is 2023
